FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

33745311000001109: Saxagliptin 5mg / Dapagliflozin 10mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
102527301000001118 Saxagliptin 5mg / Dapagliflozin 10mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
102527401000001114 Saxagliptin 5mg / Dapagliflozin 10mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has specific active ingredient Dapagliflozin propanediol monohydrate true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Is a Saxagliptin + Dapagliflozin true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has specific active ingredient Dapagliflozin propanediol monohydrate false Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has specific active ingredient Saxagliptin hydrochloride false Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Saxagliptin true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dapagliflozin false Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has active ingredient Saxagliptin true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has active ingredient Dapagliflozin true Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has basis of strength substance Saxagliptin false Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has basis of strength substance Dapagliflozin false Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets Has specific active ingredient Saxagliptin hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Qtern 5mg/10mg tablets (AstraZeneca UK Ltd) Is a True Saxagliptin 5mg / Dapagliflozin 10mg tablets Inferred relationship Existential restriction modifier
Saxagliptin 5mg / Dapagliflozin 10mg tablets 28 tablet Has VMP True Saxagliptin 5mg / Dapagliflozin 10mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start